Skip to main content

Advertisement

Log in

Microalgae, a current option for the bioremediation of pharmaceuticals: a review

  • Review
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

In this review, research on the use of microalgae as an option for bioremediation purposes of pharmaceutical compounds is reported and discussed thoroughly. Pharmaceuticals have been detected in water bodies around the world, attracting attention towards the increasing potential risks to humans and aquatic biota. Unfortunately, pharmaceuticals have no regulatory standards for safe disposal in many countries. Despite the advances in new analytical techniques, the current wastewater treatment facilities in many countries are ineffective to remove the whole presence of pharmaceutical compounds and their metabolites. Though new methods are substantially effective, removal rates of drugs from wastewater make the cost-effectiveness ratio a not viable option. Therefore, the necessity for investigating and developing more adequate removal treatments with a higher efficiency rate and at a lower cost is mandatory. The present review highlights the algae-based removal strategies for bioremediation purposes, considering their pathway as well as the removal rate and efficiency of the microalgae species used in assays. We have critically reviewed both application of living and non-living microalgae biomass for bioremediation purposes considering the most commonly used microalgae species. In addition, the use of modified and immobilized microalgae biomass for the removal of pharmaceutical compounds from water was discussed. Furthermore, research considering various microalgal species and their potential use to detoxify organic and inorganic toxic compounds were well evaluated in the review. Further research is required to exploit the potential use of microalgae species as an option for the bioremediation of pharmaceuticals in water.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Availability of data and material

Data sharing is not applicable as no new data were generated or analyzed during this study.

Code availability

Not applicable.

References

Download references

Acknowledgements

We thank S.S.S. Sarma (UNAM) for the useful discussion and revisions during the preparation of the manuscript. M.A.G.M. thanks Carlos Alberto Hernandez Duarte for the help in the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brenda Karen González-Pérez.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate

All authors consent to participate.

Consent for publication

All authors consent for publication.

Conflicts of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gayosso-Morales, M.A., Rivas-Castillo, A.M., Lucas-Gómez, I. et al. Microalgae, a current option for the bioremediation of pharmaceuticals: a review. Folia Microbiol 68, 167–179 (2023). https://doi.org/10.1007/s12223-022-01013-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12223-022-01013-z

Keywords

Navigation